Sexual functioning, sexual enjoyment, and body image in Norwegian breast cancer survivors: a 12-year longitudinal follow-up study and comparison with the general female population

References

• Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. The Lancet. 2005;365(9472):1687–1717.
   PubMed Web of Science ®Google Scholar
• Cancer registry of Norway. Cancer in Norway 2021.
   Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. The Lancet. 2011;378(9804):1707–1716.
   PubMed Web of Science ®Google Scholar
• Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011;50(2):187–193. doi: 10.3109/0284186X.2010.533190.
   PubMed Web of Science ®Google Scholar
• Abrahams H, Gielissen M, Schmits I, et al. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol. 2016;27(6):965–974. doi: 10.1093/annonc/mdw099.
   PubMed Web of Science ®Google Scholar
• Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011;12(7):725–746. doi: 10.1016/j.jpain.2010.12.005.
   PubMed Web of Science ®Google Scholar
• Mejdahl MK, Andersen KG, Gärtner R, et al. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ. 2013;346:f1865. doi: 10.1136/bmj.f1865.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang N, Zhong L, et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Mol Psychiatry. 2020;25(12):3186–3197. doi: 10.1038/s41380-020-00865-6.
   PubMed Web of Science ®Google Scholar
• Sousa Rodrigues Guedes T, Barbosa Otoni Gonçalves Guedes M, de Castro Santana R, et al. Sexual dysfunction in women with cancer: a systematic review of longitudinal studies. Int J Environ Res Public Health. 2022;19(19):11921. doi: 10.3390/ijerph191911921.
   PubMed Web of Science ®Google Scholar
• Reese JB, Sorice K, Beach MC, et al. Patient-provider communication about sexual concerns in cancer: a systematic review. J Cancer Surviv. 2017;11(2):175–188. doi: 10.1007/s11764-016-0577-9.
   PubMed Web of Science ®Google Scholar
• Parish SJ, Cottler-Casanova S, Clayton AH, et al. The evolution of the female sexual disorder/dysfunction definitions, nomenclature, and classifications: a review of DSM, ICSM, ISSWSH, and ICD. Sex Med Rev. 2021;9(1):36–56. doi: 10.1016/j.sxmr.2020.05.001.
   PubMed Web of Science ®Google Scholar
• Jing L, Zhang C, Li W, et al. Incidence and severity of sexual dysfunction among women with breast cancer: a meta-analysis based on female sexual function index. Support Care Cancer. 2019;27(4):1171–1180. doi: 10.1007/s00520-019-04667-7.
   PubMed Web of Science ®Google Scholar
• Maiorino MI, Chiodini P, Bellastella G, et al. Sexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the female sexual function index. Endocrine. 2016;54(2):329–341. doi: 10.1007/s12020-015-0812-6.
   PubMed Web of Science ®Google Scholar
• NBCG. Behandlingsskjemaer 2020
   Google Scholar
• Zehra S, Doyle F, Barry M, et al. Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis. Breast Cancer. 2020;27(4):534–566. doi: 10.1007/s12282-020-01076-1.
   PubMed Web of Science ®Google Scholar
• Munshi A, Dutta D, Kakkar S, et al. Comparison of early quality of life in patients treated with radiotherapy following mastectomy or breast conservation therapy: a prospective study. Radiother Oncol. 2010;97(2):288–293. doi: 10.1016/j.radonc.2010.04.008.
   PubMed Web of Science ®Google Scholar
• Azim H, Jr De Azambuja E, Colozza M, et al. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol. 2011;22(9):1939–1947. doi: 10.1093/annonc/mdq683.
   PubMed Web of Science ®Google Scholar
• Malinovszky K, Gould A, Foster E, et al. Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer. 2006;95(12):1626–1631. doi: 10.1038/sj.bjc.6603454.
   PubMed Web of Science ®Google Scholar
• Ferreira A, Di Meglio A, Pistilli B, et al. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol. 2019;30(11):1784–1795. doi: 10.1093/annonc/mdz298.
   PubMed Web of Science ®Google Scholar
• Battisti NML, Reed MW, Herbert E, et al. Bridging the age gap in breast cancer: impact of chemotherapy on quality of life in older women with early breast cancer. Eur J Cancer. 2021;144:269–280. doi: 10.1016/j.ejca.2020.11.022.
   PubMed Web of Science ®Google Scholar
• Smedsland SK, Vandraas KF, Bøhn SK, et al. Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey. Breast Cancer Res Treat. 2022;193:139–149. doi: 10.1007/s10549-022-06544-0.
   PubMed Web of Science ®Google Scholar
• Schover LR, Baum GP, Fuson LA, et al. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med. 2014;11(12):3102–3111. doi: 10.1111/jsm.12684.
   PubMed Web of Science ®Google Scholar
• Gandhi C, Butler E, Pesek S, et al. Sexual dysfunction in breast cancer survivors. Am J Clin Oncol. 2019;42(6):500–506. doi: 10.1097/COC.0000000000000552.
   PubMed Web of Science ®Google Scholar
• Juliato P, Rodrigues A, Stahlschmidt R, et al. Can polyacrylic acid treat sexual dysfunction in women with breast cancer receiving tamoxifen? Climacteric. 2017;20(1):62–66. doi: 10.1080/13697137.2016.1258396.
   PubMed Web of Science ®Google Scholar
• Howes BH, Watson DI, Xu C, et al. Quality of life following total mastectomy with and without reconstruction versus breast-conserving surgery for breast cancer: a case-controlled cohort study. J Plast Reconstr Aesthet Surg. 2016;69(9):1184–1191. doi: 10.1016/j.bjps.2016.06.004.
   PubMed Web of Science ®Google Scholar
• Lee C, Sunu C, Pignone M. Patient-reported outcomes of breast reconstruction after mastectomy: a systematic review. J Am Coll Surg. 2009;209(1):123–133. doi: 10.1016/j.jamcollsurg.2009.02.061.
   PubMed Web of Science ®Google Scholar
• Oberguggenberger A, Martini C, Huber N, et al. Self-reported sexual health: breast cancer survivors compared to women from the general population–an observational study. BMC Cancer. 2017;17(1):599. doi: 10.1186/s12885-017-3580-2.
   PubMed Web of Science ®Google Scholar
• Karsten MM, Roehle R, Albers S, et al. Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients. Eur J Cancer. 2022;163:128–139. doi: 10.1016/j.ejca.2021.12.020.
   PubMed Web of Science ®Google Scholar
• Reidunsdatter RJ, Albrektsen G, Hjermstad MJ, et al. One-year course of fatigue after post-operative radiotherapy in Norwegian breast cancer patients–comparison to general population. Acta Oncol. 2013;52(2):239–248. doi: 10.3109/0284186X.2012.742563.
   PubMed Web of Science ®Google Scholar
• Åsberg RE, Nilsen M, Hjermstad MJ, et al. Norwegian general population normative data for the EORTC questionnaires; the core QLQ-C30, the sexual health questionnaire QLQ-SHQ22, and the sexual domains of the QLQ-BR23/BR45. Eur J Cancer. 2023;190:112943. doi: 10.1016/j.ejca.2023.112943.
   PubMed Web of Science ®Google Scholar
• Sangha O, Stucki G, Liang MH, et al. The self‐administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156–163. doi: 10.1002/art.10993.
   PubMed Web of Science ®Google Scholar
• Alawadi SA, Ohaeri JU. Health - related quality of life of kuwaiti women with breast cancer: a comparative study using the EORTC quality of life questionnaire. BMC Cancer. 2009;9(1):222. doi: 10.1186/1471-2407-9-222.
   PubMed Web of Science ®Google Scholar
• Ahn S, Park B, Noh D, et al. Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol. 2007;18(1):173–182. doi: 10.1093/annonc/mdl333.
   PubMed Web of Science ®Google Scholar
• Pačarić S, Kristek J, Mirat J, et al. The quality of life of croatian women after mastectomy: a cross-sectional single-center study. BMC Public Health. 2018;18(1):999. doi: 10.1186/s12889-018-5929-0.
   PubMed Web of Science ®Google Scholar
• Aptecar L, Fiteni F, Jarlier M, et al. Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient’s dedicated questionnaire: a glaring gap of communication between health professionals and patients. Breast Cancer Res Treat. 2021;186(3):705–713. doi: 10.1007/s10549-020-06062-x.
   PubMed Web of Science ®Google Scholar
• Fakhari S, Pourfathi H, Farzin H, et al. Post-mastectomy phantom breast syndrome. JOGCR. 2018;3(4):1–6. doi: 10.30699/jogcr.3.4.1.
   Google Scholar
• Farthmann J, Hanjalic-Beck A, Veit J, et al. The impact of chemotherapy for breast cancer on sexual function and health-related quality of life. Support Care Cancer. 2016;24(6):2603–2609. doi: 10.1007/s00520-015-3073-2.
   PubMed Web of Science ®Google Scholar
• Martins Faria B, Martins Rodrigues I, Verri Marquez L, et al. The impact of mastectomy on body image and sexuality in women with breast cancer: a systematic review. PSIC. 2021;18(1):91–115. doi: 10.5209/psic.74534.
   Google Scholar
• Baumgart J, Nilsson K, Evers AS, et al. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 2013;20(2):162–168. doi: 10.1097/gme.0b013e31826560da.
   PubMed Web of Science ®Google Scholar
• Koch L, Jansen L, Herrmann A, et al. Quality of life in long-term breast cancer survivors–a 10-year longitudinal population-based study. Acta Oncol. 2013;52(6):1119–1128. doi: 10.3109/0284186X.2013.774461.
   PubMed Web of Science ®Google Scholar
• Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–144. doi: 10.1200/JCO.1998.16.1.139.
   PubMed Web of Science ®Google Scholar
• Imran M, Al-Wassia R, Alkhayyat SS, et al. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: a tertiary care center survey in the Western region of Saudi Arabia. PLoS One. 2019;14(7):e0219093. doi: 10.1371/journal.pone.0219093.
   PubMed Web of Science ®Google Scholar
• Tan ML, Idris DB, Teo LW, et al. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore. Asia Pac J Oncol Nurs. 2014;1(1):22–32. doi: 10.4103/2347-5625.135817.
   PubMedGoogle Scholar
• Teo I, Novy DM, Chang DW, et al. Examining pain, body image, and depressive symptoms in patients with lymphedema secondary to breast cancer. Psychooncology. 2015;24(11):1377–1383. doi: 10.1002/pon.3745.
   PubMed Web of Science ®Google Scholar
• Nilsen M, Stalsberg R, Sand K, et al. Meaning making for psychological adjustment and quality of life in older long-term breast cancer survivors. Front Psychol. 2021;12:734198. doi: 10.3389/fpsyg.2021.734198.
   PubMed Web of Science ®Google Scholar
• Oberguggenberger AS, Nagele E, Inwald EC, et al. Phase 1–3 of the cross‐cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ‐22. Cancer Med. 2018;7(3):635–645. doi: 10.1002/cam4.1338.
   PubMed Web of Science ®Google Scholar
• Pilz MJ, Gamper EM, Efficace F, et al. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals. BMC Public Health. 2022;22(1):1040. doi: 10.1186/s12889-022-13211-y.
   PubMed Web of Science ®Google Scholar